BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12768230)

  • 1. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
    Elad S; Or R; Resnick I; Shapira MY
    Transpl Int; 2003 Sep; 16(9):665-70. PubMed ID: 12768230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral graft vs. host disease in children--treatment with topical tacrolimus ointment.
    Albert MH; Becker B; Schuster FR; Klein B; Binder V; Adam K; Nienhoff C; Führer M; Borkhardt A
    Pediatr Transplant; 2007 May; 11(3):306-11. PubMed ID: 17430488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
    Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
    Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
    Uberti JP; Ayash L; Braun T; Reynolds C; Silver S; Ratanatharathorn V
    Bone Marrow Transplant; 2004 Sep; 34(5):425-31. PubMed ID: 15273705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cutaneous chronic graft-versus-host disease with topical pimecrolimus.
    Schmook T; Kraft J; Benninghoff B; Nindl I; Roewert J; Ulrich C; Stockfleth E
    Bone Marrow Transplant; 2005 Jul; 36(1):87-8. PubMed ID: 15895116
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease.
    Prot-Labarthe S; Therrien R; Champagne MA; Duval M; Joubert C
    Bone Marrow Transplant; 2007 Aug; 40(3):295-6. PubMed ID: 17549052
    [No Abstract]   [Full Text] [Related]  

  • 7. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
    Cutler C; Kim HT; Hochberg E; Ho V; Alyea E; Lee SJ; Fisher DC; Miklos D; Levin J; Sonis S; Soiffer RJ; Antin JH
    Biol Blood Marrow Transplant; 2004 May; 10(5):328-36. PubMed ID: 15111932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.
    Couriel DR; Saliba R; Escalón MP; Hsu Y; Ghosh S; Ippoliti C; Hicks K; Donato M; Giralt S; Khouri IF; Hosing C; de Lima MJ; Andersson B; Neumann J; Champlin R
    Br J Haematol; 2005 Aug; 130(3):409-17. PubMed ID: 16042691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus.
    Ziemer M; Gruhn B; Thiele JJ; Elsner P
    J Am Acad Dermatol; 2004 Jun; 50(6):946-8. PubMed ID: 15153900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide: a novel treatment for oral chronic graft versus host disease.
    Elad S; Or R; Garfunkel AA; Shapira MY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Mar; 95(3):308-11. PubMed ID: 12627101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report.
    Sánchez AR; Sheridan PJ; Rogers RS
    J Periodontol; 2004 Apr; 75(4):613-9. PubMed ID: 15152828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease].
    Firmin D; Karam A; Guillerm G; Roguedas AM; Berthou C; Misery L
    Ann Dermatol Venereol; 2008 Mar; 135(3):234-6. PubMed ID: 18374862
    [No Abstract]   [Full Text] [Related]  

  • 14. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients.
    Choi CJ; Nghiem P
    Arch Dermatol; 2001 Sep; 137(9):1202-6. PubMed ID: 11559218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
    Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
    Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
    Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
    Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
    Ringdén O; Uzunel M; Rasmusson I; Remberger M; Sundberg B; Lönnies H; Marschall HU; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
    Transplantation; 2006 May; 81(10):1390-7. PubMed ID: 16732175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.